l-carnitine pancreatic cancer SERPINB3-MYC axis induces the basal-like/squamous
SERPINB3 MYC axis induces the basal like squamous subtype and enhances disease progression in pancreatic cancer ScienceDirect Serum carnitine and cancer risk: a Mendelian randomization study identifying pancreatic cancer as a modifiable metabolic target Discover Oncology Springer Nature Link Dysfunction of the carnitine cycle in tumor progression: Heliyon L Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine PMC PDF) L Carnitine supplementation in advanced pancreatic cancer (CARPAN) A randomized multicentre trial Carnitine Memorial Sloan Kettering Cancer Center
Pay in 4 interest-free payments of $5.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





